Takebayashi Kohzo, Yamauchi Mototaka, Hara Kenji, Tsuchiya Takafumi, Hashimoto Koshi
Department of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center, Koshigaya, JPN.
Cureus. 2024 Jul 13;16(7):e64444. doi: 10.7759/cureus.64444. eCollection 2024 Jul.
The main purpose of the current study was to investigate the effect of season change and the influence of the COVID-19 pandemic on the ratio of glycoalbumin to hemoglobin A1c (GA/HbA1c) in patients with type 2 diabetes.
A total of 267 patients in whom both HbA1c and GA were measured at baseline were included in this retrospective study. GA/HbA1c was investigated for three years, 2018, 2019, and 2020 (COVID-19 pandemic period).
The mean values for GA/HbA1c per year in 2018, 2019, and 2020 were 2.64±0.35, 2.61±0.35, 2.64±0.39, respectively. There were no significant differences in GA/HbA1c during these years. There was a tendency toward seasonal variation in GA/HbA1c (i.e., higher in summer or autumn and lower in spring or winter).
In patients with type 2 diabetes, GA/HbA1c tended to show seasonal variation, which was not influenced by the COVID-19 pandemic.
本研究的主要目的是调查季节变化以及2019冠状病毒病大流行对2型糖尿病患者糖化白蛋白与糖化血红蛋白A1c比值(GA/HbA1c)的影响。
本回顾性研究纳入了267例在基线时同时测量了HbA1c和GA的患者。对2018年、2019年和2020年(2019冠状病毒病大流行期间)这三年的GA/HbA1c进行了调查。
2018年、2019年和2020年每年GA/HbA1c的平均值分别为2.64±0.35、2.61±0.35、2.64±0.39。这些年份的GA/HbA1c无显著差异。GA/HbA1c存在季节性变化趋势(即夏季或秋季较高,春季或冬季较低)。
在2型糖尿病患者中,GA/HbA1c往往呈现季节性变化,且不受2019冠状病毒病大流行的影响。